The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 7, 2014, Pages 1985-1992

  Hollister, Kristin ^a   Chen, Yuxin ^b   Wang, Shixia ^b   Wu, Hao ^a   Mondal, Arpita ^a   Clegg, Ninah ^a   Lu, Shan ^b   Dent, Alexander ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

BCL6; Follicular helper T cells; Germinal center; HIV vaccine; Prime boost

Indexed keywords

DNA VACCINE; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G; BCL6 PROTEIN, MOUSE; DNA BINDING PROTEIN; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PROTEIN BCL 6; SUBUNIT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DNA IMMUNIZATION; FEMALE; GERMINAL CENTER; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MALE; MEMORY CELL; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; ANIMAL; BLOOD; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PROCEDURES; VACCINATION;

AIDS VACCINES; ANIMALS; B-LYMPHOCYTES; DNA-BINDING PROTEINS; FEMALE; GERMINAL CENTER; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; IMMUNOGLOBULIN G; MALE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-BCL-6; T-LYMPHOCYTES, HELPER-INDUCER; VACCINATION; VACCINES, DNA; VACCINES, SUBUNIT;

EID: 84908376053     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.28659     Document Type: Article

References (31)

1. Koff WC, Burton DR, Johnson PR, Walker BD, King CR, Nabel GJ, Ahmed R, Bhan MK, Plotkin SA. Accelerating next-generation vaccine development for global disease prevention. Science 2013; 340:1232910; PMID:23723240; http://dx.doi.org/10.1126/science.1232910
2. Burton DR, Desrosiers RC, Doms RW, Koff WC, Kwong PD, Moore JP, Nabel GJ, Sodroski J, Wilson IA, Wyatt RT. HIV vaccine design and the neutralizing antibody problem. Nat Immunol 2004; 5:233-6; PMID:14985706; http://dx.doi.org/10.1038/ni0304-233
3. MacLennan ICM. Germinal centers. Annu Rev Immunol 1994; 12:117-39; PMID:8011279; http://dx.doi.org/10.1146/annurev.iy.12.040194.001001
4. Tarlinton DM. Evolution in miniature: selection, survival and distribution of antigen reactive cells in the germinal centre. Immunol Cell Biol 2008; 86:133-8; PMID:18180800; http://dx.doi.org/10.1038/sj.icb.7100148
5. Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8:22-33; PMID:18097447; http://dx.doi.org/10.1038/nri2217
6. Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: lineage and location. Immunity 2009; 30:324-35; PMID:19303387; http://dx.doi.org/10.1016/j.immuni.2009.03.003
7. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011; 29:621-63; PMID:21314428; http://dx.doi.org/10.1146/annurev-immunol-031210-101400
8. Hollowood K, Macartney J. Cell kinetics of the germinal center reaction - a stathmokinetic study. Eur J Immunol 1992; 22:261-6; PMID:1730253; http://dx.doi.org/10.1002/eji.1830220138
9. Vasan S, Schlesinger SJ, Huang Y, Hurley A, Lombardo A, Chen Z, Than S, Adesanya P, Bunce C, Boaz M, et al. Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B′ HIV-1 candidate vaccine. PLoS One 2010; 5:e8617; PMID:20111582; http://dx.doi.org/10.1371/journal.pone.0008617
10. Dou J, Wang Y, Yu F, Yang H, Wang J, He X, Xu W, Chen J, Hu K. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting. Int J Immunogenet 2012; 39:183-90; PMID:22152009; http://dx.doi.org/10.1111/j.1744-313X.2011.01066.x
11. Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, Patterson N, Guerrero M, Bennett JW, McGrath S, et al. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS One 2013; 8:e55571; PMID:23457473; http://dx.doi.org/10.1371/journal.pone.0055571
12. Lu S. Heterologous prime-boost vaccination. Curr Opin Immunol 2009; 21:346-51; PMID:19500964; http://dx.doi.org/10.1016/j.coi.2009.05.016
13. Vaine M, Wang S, Hackett A, Arthos J, Lu S. Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity. Vaccine 2010; 28:2999-3007; PMID:20170767; http://dx.doi.org/10.1016/j.vaccine.2010.02.006
14. Wang S, Arthos J, Lawrence JM, Van Ryk D, Mboudjeka I, Shen S, Chou TH, Montefiori DC, Lu S. Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1. J Virol 2005; 79:7933-7; PMID:15919951; http://dx.doi.org/10.1128/JVI.79.12.7933-7937.2005
15. Wang S, Pal R, Mascola JR, Chou T-HW, Mboudjeka I, Shen S, Liu Q, Whitney S, Keen T, Nair BC, et al. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. Virology 2006; 350:34-47; PMID:16616287; http://dx.doi.org/10.1016/j.virol.2006.02.032
16. Taylor JJ, Pape KA, Jenkins MK. A germinal center-independent pathway generates unswitched memory B cells early in the primary response. J Exp Med 2012; 209:597-606; PMID:22370719; http://dx.doi.org/10.1084/jem.20111696
17. Hollister K, Kusam S, Wu H, Clegg N, Mondal A, Sawant DV, Dent AL. Insights into the role of Bcl6 in follicular Th cells using a new conditional mutant mouse model. J Immunol 2013; 191:3705-11; PMID:23980208; http://dx.doi.org/10.4049/jimmunol.1300378
18. Jacobs SR, Michalek RD, Rathmell JC. IL-7 is essential for homeostatic control of T cell metabolism in vivo. J Immunol 2010; 184:3461-9; PMID:20194717; http://dx.doi.org/10.4049/jimmunol.0902593
19. Sawamukai N, Satake A, Schmidt AM, Lamborn IT, Ojha P, Tanaka Y, Kambayashi T. Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD. Blood 2012; 119:5575-83; PMID:22496155; http://dx.doi.org/10.1182/blood-2011-07-367987
20. Coban C, Koyama S, Takeshita F, Akira S, Ishii KJ. Molecular and cellular mechanisms of DNA vaccines. Hum Vaccin 2008; 4:453-6; PMID:18535407; http://dx.doi.org/10.4161/hv.4.6.6200
21. Catanzaro AT, Roederer M, Koup RA, Bailer RT, Enama ME, Nason MC, Martin JE, Rucker S, Andrews CA, Gomez PL, et al.; VRC 007 Study Team. Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine. Vaccine 2007; 25:4085-92; PMID:17391815; http://dx.doi.org/10.1016/j.vaccine.2007.02.050
22. Koblin BA, Casapia M, Morgan C, Qin L, Wang ZM, Defawe OD, Baden L, Goepfert P, Tomaras GD, Montefiori DC, et al.; NIAID HIV Vaccine Trials Network. Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial. PLoS One 2011; 6:e24517; PMID:21931737; http://dx.doi.org/10.1371/journal.pone.0024517
23. Bakari M, Aboud S, Nilsson C, Francis J, Buma D, Moshiro C, Aris EA, Lyamuya EF, Janabi M, Godoy-Ramirez K, et al. Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine 2011; 29:8417-28; PMID:21864626; http://dx.doi.org/10.1016/j.vaccine.2011.08.001
24. Koup RA, Roederer M, Lamoreaux L, Fischer J, Novik L, Nason MC, Larkin BD, Enama ME, Ledgerwood JE, Bailer RT, et al.; VRC 009 Study Team; VRC 010 Study Team. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses. PLoS One 2010; 5:e9015; PMID:20126394; http://dx.doi.org/10.1371/journal.pone.0009015
25. Lu S. Human versus HIV: round 2 defeat in AIDS vaccine development. Expert Rev Vaccines 2008; 7:151-3; PMID:18324884; http://dx.doi.org/10.1586/14760584.7.2.151
26. Lindqvist M, van Lunzen J, Soghoian DZ, Kuhl BD, Ranasinghe S, Kranias G, Flanders MD, Cutler S, Yudanin N, Muller MI, et al. Expansion of HIV-specific T follicular helper cells in chronic HIV infection. J Clin Invest 2012; 122:3271-80; PMID:22922259; http://dx.doi.org/10.1172/JCI64314
27. Perreau M, Savoye A-L, De Crignis E, Corpataux J-M, Cubas R, Haddad EK, De Leval L, Graziosi C, Pantaleo G. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 2013; 210:143-56; PMID:23254284; http://dx.doi.org/10.1084/jem.20121932
28. Xu Y, Weatherall C, Bailey M, Alcantara S, De Rose R, Estaquier J, Wilson K, Suzuki K, Corbeil J, Cooper DA, et al. Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques. J Virol 2013; 87:3760-73; PMID:23325697; http://dx.doi.org/10.1128/JVI.02497-12
29. + memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 2013; 39:758-69; PMID:24035365; http://dx.doi.org/10.1016/j.immuni.2013.08.031
30. Choi YS, Yang JA, Yusuf I, Johnston RJ, Greenbaum J, Peters B, Crotty S. Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J Immunol 2013; 190:4014-26; PMID:23487426; http://dx.doi.org/10.4049/jimmunol.1202963
31. Ruzankina Y, Pinzon-Guzman C, Asare A, Ong T, Pontano L, Cotsarelis G, Zediak VP, Velez M, Bhandoola A, Brown EJ. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 2007; 1:113-26; PMID:18371340; http://dx.doi.org/10.1016/j.stem.2007.03.002